Cargando…

Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes

BACKGROUND: Radiomics-based non-invasive biomarkers are promising to facilitate the translation of therapeutically related molecular subtypes for treatment allocation of patients with head and neck squamous cell carcinoma (HNSCC). METHODS: We included 113 HNSCC patients from The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chao, Cintra, Murilo, Brennan, Kevin, Zhou, Mu, Colevas, A. Dimitrios, Fischbein, Nancy, Zhu, Shankuan, Gevaert, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642281/ https://www.ncbi.nlm.nih.gov/pubmed/31255659 http://dx.doi.org/10.1016/j.ebiom.2019.06.034

Ejemplares similares

Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype
por: Brennan, K., et al.
Publicado: (2017)

Skull base osteomyelitis in patients with head and neck cancer: Diagnosis, management, and outcomes in a case series of 23 patients
por: Czech, Mary M., et al.
Publicado: (2022)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
por: Iberri, David J., et al.
Publicado: (2016)

Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades
por: Wu, Wenli, et al.
Publicado: (2019)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
por: Trieu, Vanessa, et al.
Publicado: (2018)

Evaluation of the MVCT-based radiomic features as prognostic factor in patients with head and neck squamous cell carcinoma
por: Abe, Kota, et al.
Publicado: (2023)

The importance of feature aggregation in radiomics: a head and neck cancer study
por: Fontaine, Pierre, et al.
Publicado: (2020)

Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models
por: Liu, Xiaoyang, et al.
Publicado: (2021)

Development of a Model Based on Delta-Radiomic Features for the Optimization of Head and Neck Squamous Cell Carcinoma Patient Treatment
por: Šedienė, Severina, et al.
Publicado: (2023)

Commentary on “Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data”
por: Colevas, A. Dimitrios
Publicado: (2017)

Benchmarking Eliminative Radiomic Feature Selection for Head and Neck Lymph Node Classification
por: Bardosi, Zoltan R., et al.
Publicado: (2022)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Su, Kaixin, et al.
Publicado: (2022)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
por: Haider, Stefan P., et al.
Publicado: (2020)

Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I)
por: Bernatz, Simon, et al.
Publicado: (2023)

Radiomic features based on Hessian index for prediction of prognosis in head-and-neck cancer patients
por: Le, Quoc Cuong, et al.
Publicado: (2020)

Radiomics in Head and Neck Cancer Outcome Predictions
por: Gonçalves, Maria, et al.
Publicado: (2022)

Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer
por: Chuang, Yi-Hsuan, et al.
Publicado: (2023)

Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors
por: Bard, Jonathan E., et al.
Publicado: (2022)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Cancer associated fibroblast derived gene signature determines cancer subtypes and prognostic model construction in head and neck squamous cell carcinomas
por: Wu, Sangqing, et al.
Publicado: (2022)

Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
por: Xu, Chengbo, et al.
Publicado: (2023)

Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma
por: Fatima, Kashuf, et al.
Publicado: (2021)

A Radiomics Approach to Identify Immunologically Active Tumor in Patients with Head and Neck Squamous Cell Carcinomas
por: Nguyen, Tan Mai, et al.
Publicado: (2023)

Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma
por: Aye, Ling, et al.
Publicado: (2023)

Improving radiomic model reliability using robust features from perturbations for head-and-neck carcinoma
por: Teng, Xinzhi, et al.
Publicado: (2022)

NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
por: Brennan, Kevin, et al.
Publicado: (2017)

Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2021)

Radiomics and Machine Learning for Radiotherapy in Head and Neck Cancers
por: Giraud, Paul, et al.
Publicado: (2019)

Application of radiomics and machine learning in head and neck cancers
por: Peng, Zhouying, et al.
Publicado: (2021)

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers
por: Gul, Maryam, et al.
Publicado: (2021)

Current Role of Delta Radiomics in Head and Neck Oncology
por: Marcu, David C., et al.
Publicado: (2023)

Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
por: Huynh, Bao Ngoc, et al.
Publicado: (2023)

Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma
por: Qadir, Fatima, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_50dfbb4qedjj21pg8c4hkratkm